Last reviewed · How we verify
NCT03783858
Image Collection of Normal Eyes for Development of an EU RDB
NA trial testing P200TE in Healthy in 356 participants. Completed in 20 April 2020.
8 October 2019
Quick facts
| Lead sponsor | Optos, PLC |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | other |
| Enrollment | 356 |
| Start date | 30 May 2019 |
| Primary completion | 8 October 2019 |
| Estimated completion | 20 April 2020 |
| Sites | 5 locations across United Kingdom |
Drugs / interventions tested
- P200TE
Conditions studied
- Healthy — all drugs for Healthy →
Sponsor
Optos, PLC
Who can join
22 and older, any sex, with Healthy. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study is designed to collect in-tissue OCT scans on the Optos P200TE on normal healthy eyes to develop a EU reference database
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT03783858
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of P200TE
Trials testing the same drug.
- NCT06305481 — Glaucoma Evaluation With the P200TE · NA · completed
- NCT05844852 — P200TE US Reference Database Study · NA · active not recruiting
- NCT05536401 — P200TE Agreement and Precision Study · NA · terminated
- NCT03912584 — Study Comparing the P200TE and the P200TxE in Glaucoma Patients · NA · completed
Other recruiting trials for Healthy
Currently open trials in the same condition.
- NCT06707207 — Predicting Future Errors During Skill Performance · recruiting
- NCT07169630 — PET Imaging of Phosphodiesterase-4 (PDE4) in Volunteers With Alzheimer Disease (AD) or Mild Cognitive Impairment (MCI) · Phase 1 · recruiting
- NCT07499414 — The Effects of the Bile Acid Supplement, 7-keto Lithocholic Acid, on Human Gut Microbiota and Risk Factors for Disease. · NA · recruiting
- NCT07496697 — Effects of Electroacupuncture at NP82 and SP15 on Bowel Motility in Healthy Subjects · NA · recruiting
- NCT06431932 — Pilot Trial of Fisetin in Healthy Volunteers and Older Patients With Multimorbidity · Phase 1, PHASE2 · recruiting
Other Optos, PLC trials
Trials by the same sponsor.
- NCT07149740 — Data Gathering for A10900 · recruiting
- NCT06305481 — Glaucoma Evaluation With the P200TE · NA · completed
- NCT06269666 — P200TxE Diseased Eye Image Collection · NA · recruiting
- NCT05844852 — P200TE US Reference Database Study · NA · active not recruiting
- NCT05532410 — Optic Disc Photograph Collection Study · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03783858 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Optos, PLC
- Last refreshed: 9 June 2020
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03783858.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing